as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
1.61%
Downside
4.42%
Upside
52 Week's Low
52 Week's High
73.49%
Downside
20.46%
Upside
Check Caribou Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$235.6M
EPS (TTM)
-1.64
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.54
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-146.3M
Revenue (TTM)
9.1M
Profit Margin
0.00%
Return On Equity TTM
-68.93%
Track how Caribou Biosciences P/E has moved over time to understand its valuation trends.
Caribou Biosciences in the last 5 years
Lowest (-6.17x)
September 30, 2022
Today (-1.54x)
October 24, 2025
Industry (-0.88x)
October 24, 2025
Highest (-0.63x)
June 30, 2025
Today’s Price to Earnings Ratio: -1.54x
Compare market cap, revenue, PE, and other key metrics of Caribou Biosciences with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $235.6M | NA | -1.54 | 0.00% | |
| BUY | $60.9B | 251.94% | -505.15 | -12.96% | |
| NA | $35.9B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.75% | 30.31 | 31.86% | |
| BUY | $62.0B | -0.71% | 14.73 | 31.37% |
The Caribou Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Caribou Biosciences investment value today
Current value as on today
₹1,41,375
Returns
₹41,375
(+41.38%)
Returns from Caribou Biosciences Stock
₹36,813 (+36.81%)
Dollar Returns*
₹4,562 (+4.56%)
Based on 15 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 15 analysts, 86.67% of analysts recommend a 'BUY' rating for Caribou Biosciences. Average target price of $8.86
Get share price movements and forecasts by analysts on Caribou Biosciences.
What analysts predicted
71.9%UPSIDE
Target Price
$8.86
Current Price
$2.49
Analyzed by
15 Analysts
Target
$8.86
Caribou Biosciences target price $8.86, a slight upside of 71.9% compared to current price of $2.49. According to 15 analysts rating.
Search interest for Caribou Biosciences Stock has increased by 129% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:129% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 2.02M → 2.66M (in $), with an average increase of 8.7% per quarter
Price Rise
![]()
In the last 1 month, CRBU stock has moved up by 17.4%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.0% return, outperforming this stock by 20.6%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 136.9% return, outperforming this stock by 210.5%
Profit Down
![]()
Netprofit is down for the last 4 quarters, -34.68M → -54.09M (in $), with an average decrease of 16.8% per quarter
| Organisation | Caribou Biosciences |
| Headquarters | 2929 7th Street, Berkeley, CA, United States, 94710 |
| Industry | Services |
| CEO | Dr. Rachel E. Haurwitz Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Rachel E. Haurwitz Ph.D. | Co-Founder, CEO, President & Director |
Mr. Sriram Ryali M.B.A. | Chief Financial Officer |
Mr. Ryan Fischesser | Interim Principal Accounting Officer & Controller |
Ms. Reigin Zawadzki | Chief People Officer |
Ms. Ruhi A. Khan M.B.A. | Chief Business Officer |
Mr. Timothy P. Kelly M.B.A. | Chief Technology Officer |
Ms. Barbara G. McClung Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Daniel Poon | Vice President of Operations & Information Technology |
Ms. Amy Figueroa C.F.A. | Vice President of Investor Relations & Corporate Communications |
Dr. Tina Albertson M.D., Ph.D. | Chief Medical Officer |
Caribou Biosciences share price today is $2.49 as on at the close of the market. Caribou Biosciences share today touched a day high of $2.6 and a low of $2.45.
Caribou Biosciences share touched a 52 week high of $3 on and a 52 week low of $0.66 on . Caribou Biosciences stock price today i.e. is closed at $2.49,which is 16.99% down from its 52 week high and 277.27% up from its 52 week low.
Caribou Biosciences market capitalisation is $0.00T as on .
Indian investors can start investing in Caribou Biosciences (CRBU) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Caribou Biosciences stock (as per the Rupee-Dollar exchange rate as on ).
Based on Caribou Biosciences share’s latest price of $2.49 as on October 25, 2025 at 1:29 am IST, you will get 4.0161 shares of Caribou Biosciences. Learn more about
fractional shares .